An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
about
NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.
P2860
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@en
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@nl
type
label
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@en
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@nl
prefLabel
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@en
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@nl
P2093
P2860
P356
P1433
P1476
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2016.487
P407
P577
2017-01-23T00:00:00Z
P6179
1074214825